Neurosonix

Neurosonix is a medical technology company specializing in the development of ultrasound-based systems for cardiovascular and neurological interventions. The company's primary technology, the EmboSafe system, is designed to non-invasively detect and fragment emboli—such as blood clots and air bubbles—during cardiac surgery to prevent perioperative stroke and cognitive decline. Beyond embolic protection, Neurosonix has explored ultrasound-mediated drug delivery platforms, utilizing acoustic energy to enhance the transport of therapeutics across biological barriers like the blood-brain barrier. Headquartered in Israel, the company leverages its proprietary ultrasound platform to address critical unmet needs in stroke prevention and localized drug administration.